[Resistance of falciparum malaria to 4-aminoquinolines].
D000328:Adult; D000634:Aminoquinolines / Q000494:pharmacology*; D002701:Chloramphenicol / Q000627:therapeutic use; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum / Q000187:drug effects*; D011319:Primaquine / Q000494:pharmacology / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use
D000634:Aminoquinolines; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D002701:Chloramphenicol; D013413:Sulfadoxine; D002738:Chloroquine; C001920:4-aminoquinoline; D011319:Primaquine; D011739:Pyrimethamine
Resistencia de paludismo falciparum a las 4-aminoquinoleínas.